Asahi Life Asset Management Co., Ltd. Incyte Corp Transaction History

Asahi Life Asset Management Co., Ltd.

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$52.16 - $64.19 $39,380 - $48,463	755 Added 16.54%	5,320 $334,000
Q3 2023 Nov 02, 2023	BUY	$57.77 - $65.93 $288 - $329	5 Added 0.11%	4,565 $263,000
Q2 2023 Jul 21, 2023	BUY	$60.95 - $75.51 $45,712 - $56,632	750 Added 19.69%	4,560 $283,000
Q1 2023 May 01, 2023	BUY	$70.23 - $86.01 $267,576 - $327,698	3,810 New	3,810 $275,000
Q3 2022 Nov 07, 2022	BUY	$66.18 - $82.86 $263,396 - $329,782	3,980 New	3,980 $265,000
Q1 2022 May 11, 2022	SELL	$66.02 - $79.71 $386,877 - $467,100	-5,860 Closed	0 $0
Q4 2021 Feb 02, 2022	BUY	$63.34 - $74.11 $31,036 - $36,313	490 Added 9.12%	5,860 $430,000
Q3 2021 Oct 29, 2021	BUY	$68.67 - $84.02 $33,648 - $41,169	490 Added 10.04%	5,370 $369,000
Q2 2021 Aug 10, 2021	BUY	$79.87 - $87.53 $798 - $875	10 Added 0.21%	4,880 $411,000
Q1 2021 May 07, 2021	BUY	$76.02 - $100.5 $36,489 - $48,240	480 Added 10.93%	4,870 $396,000
Q4 2020 Feb 12, 2021	BUY	$80.74 - $97.7 $354,448 - $428,903	4,390 New	4,390 $382,000
Q3 2019 Nov 13, 2019	SELL	$72.82 - $86.52 $308,756 - $366,844	-4,240 Closed	0 $0
Q2 2019 Aug 09, 2019	BUY	$73.52 - $88.7 $311,724 - $376,088	4,240 New	4,240 $360,000

644

186M

714K

557K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16.6B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Asahi Life Asset Management Co., Ltd., based on Form 13F filings with the SEC.

Stay updated on Asahi Life Asset Management Co., Ltd. with notifications on news.